Skip to the page

Data / Form D filings / Innovative Therapeutix, Inc.

Innovative Therapeutix, Inc.: Form D filings

Innovative Therapeutix, Inc., a company in Louisville, KY, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on January 5, 2023, reports $40,000 sold of a $40,000 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3032 NADINA DR., Louisville, KY, 40220
Phone
(618) 974-8907
Industry
Other
Entity type
Corporation
Incorporated in
Kentucky
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1908403

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 5, 2023New notice$40,000$40,0001Dec 15, 2022sec.gov
Feb 2, 2022New notice$600,000$170,000$430,0007Dec 14, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Robert R. SaundersDirector
Rebekah R. GossomDirector
Michael R. DetmerExecutive Officer, Director

Other companies in Kentucky that filed recently

Every Form D from the week of Jan 2, 2023 · All recent filings in Kentucky · All recent Other filings

Read from SEC EDGAR. Amount sold is what Innovative Therapeutix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.